Register entry
- Registered sites
- 0
- Active NDC listings
- 4
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
44 active NDC listings: 4 human prescription drug. By marketing category: NDA 4.
| Dosage form | NDCs |
|---|---|
| capsule, gelatin coated | 4 |
| Route | NDCs |
|---|---|
| oral | 4 |
| Labeller name on the listing | NDCs |
|---|---|
| myokardia, inc. | 4 |
Catalogue
Marketed products
4| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| CAMZYOS | mavacamten | capsule, gelatin coated, oral | 73625-111NDA |
| CAMZYOS | mavacamten | capsule, gelatin coated, oral | 73625-112NDA |
| CAMZYOS | mavacamten | capsule, gelatin coated, oral | 73625-113NDA |
| CAMZYOS | mavacamten | capsule, gelatin coated, oral | 73625-114NDA |
Compare
Other companies listing mavacamten
- Patheon Manufacturing Services LLC19 sites · 319 NDC
Enquiry
Common questions
- Is Myokardia, Inc. FDA approved?
- Myokardia, Inc. holds no registered establishment of its own; 4 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Myokardia, Inc. make?
- 4 products are listed under Myokardia, Inc. in the openFDA NDC Directory, most often as capsule, gelatin coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.